Our group has already achieved interesting results by using PNA-mediated inhibition of MYCN in neuroblastoma cell lines [19, 27] while other studies supported the possible applications of anti-gene oligonucleotide strategies in hematologic malignancies [28, 29]. This evidence concerns the gene MYCN and neuroblastoma.